Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Methods (San Diego, Calif.)
|
April 29, 2014
Methodological considerations for mutagen exposure in C. elegans
Zebulin Kessler, Judith Yanowitz
Genetics
|
September 23, 2018
Meiotic Double-Strand Break Proteins Influence Repair Pathway Utilization
Nicolas Macaisne, Zebulin Kessler, Judith L Yanowitz
Current Biology : CB
|
May 7, 2016
The p53-like Protein CEP-1 Is Required for Meiotic Fidelity in C. elegans
Abigail-Rachele F Mateo, Zebulin Kessler, Anita Kristine Jolliffe, et al.
Genes & Development
|
September 20, 2015
REC-1 and HIM-5 distribute meiotic crossovers and function redundantly in meiotic double-strand break formation in Caenorhabditis elegans
George Chung, Ann M Rose, Mark I R Petalcorin, et al.
JAMA Oncology
|
December 20, 2019
Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries
Steven T Bird, Fang Tian, Natasha Flowers, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Methods (San Diego, Calif.)
|
April 29, 2014
Methodological considerations for mutagen exposure in C. elegans
Zebulin Kessler, Judith Yanowitz
Genetics
|
September 23, 2018
Meiotic Double-Strand Break Proteins Influence Repair Pathway Utilization
Nicolas Macaisne, Zebulin Kessler, Judith L Yanowitz
Current Biology : CB
|
May 7, 2016
The p53-like Protein CEP-1 Is Required for Meiotic Fidelity in C. elegans
Abigail-Rachele F Mateo, Zebulin Kessler, Anita Kristine Jolliffe, et al.
Genes & Development
|
September 20, 2015
REC-1 and HIM-5 distribute meiotic crossovers and function redundantly in meiotic double-strand break formation in Caenorhabditis elegans
George Chung, Ann M Rose, Mark I R Petalcorin, et al.
JAMA Oncology
|
December 20, 2019
Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare Beneficiaries
Steven T Bird, Fang Tian, Natasha Flowers, et al.
Page
of 1